Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
850.93B
Market cap850.93B
Price-Earnings ratio
39.67
Price-Earnings ratio39.67
Dividend yield
0.68%
Dividend yield0.68%
Average volume
2.88M
Average volume2.88M
High today
$911.00
High today$911.00
Low today
$895.61
Low today$895.61
Open price
$905.71
Open price$905.71
Volume
744.85K
Volume744.85K
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

The current Eli Lilly(LLY) stock price is $900.13, with a market capitalization of 850.93B. The stock trades at a price-to-earnings (P/E) ratio of 39.67 and offers a dividend yield of 68.4%.

As of 2026-03-24, Eli Lilly(LLY) stock has fluctuated between $895.61 and $911.00. The current price stands at $900.13, placing the stock +0.5% above today's low and -1.2% off the high.

Eli Lilly(LLY) shares are trading with a volume of 744.85K, against a daily average of 2.88M.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.

LLY News

24/7 Wall St. 1h
With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize

With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize By John Seetoo Published Mar 24, 10:07AM EDT Quick Read iShares U.S. Pharm...

With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize
Zacks 2h
The Zacks Analyst Blog Highlights Eli Lilly, RTX, Abbott Laboratories, Ohio Valley Banc and Rave Restaurant

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All...

The Zacks Analyst Blog Highlights Eli Lilly, RTX, Abbott Laboratories, Ohio Valley Banc and Rave Restaurant
Benzinga 2h
Eli Lilly To Phase Out Select Insulin Products Across Europe By 2027

The withdrawals, which vary by country, are expected to be completed before the second quarter of 2027. Select Insulin Products To Be Withdrawn By 2027 The co...

Eli Lilly To Phase Out Select Insulin Products Across Europe By 2027

Analyst ratings

83%

of 35 ratings
Buy
82.9%
Hold
14.3%
Sell
2.9%

More LLY News

Simply Wall St 17h
Eli Lilly Weight Loss Push Weighs On Valuation And Growth Hopes

FDA decision pending on Eli Lilly’s oral weight loss drug orforglipron, a key regulatory milestone for NYSE:LLY. Company planning a US$3b investment in China t...

Eli Lilly Weight Loss Push Weighs On Valuation And Growth Hopes
Benzinga 22h
What's Going On With Eli Lilly On Monday?

More than 80 global executives gathered in Beijing for the China Development Forum, signaling renewed corporate interest in the Chinese market despite ongoing g...

What's Going On With Eli Lilly On Monday?
TipRanks 1d
Eli Lilly Stock Faces This Make-or-Break Test on April 10

Investors considering taking a position in Eli Lilly (LLY) stock might want to do so before April 10. That’s the date when the U.S. Food and Drug Administratio...

Nasdaq 1d
Prediction: This Unstoppable Growth Stock Will Be Worth $2 Trillion in the Next 7 Years

Key Points Eli Lilly is likely to remain the leader in the rapidly expanding weight management market for some time. The company's lineup and pipeline look div...

Prediction: This Unstoppable Growth Stock Will Be Worth $2 Trillion in the Next 7 Years
Nasdaq 2d
Should You Buy Eli Lilly Stock Before April 10?

Key Points Eli Lilly dominates the U.S. weight loss drug market. The company’s weight loss portfolio brought in more than $11 billion in the latest quarter....

Should You Buy Eli Lilly Stock Before April 10?
The Motley Fool 3d
Is This Stock a Buy on the Dip?

After becoming the first healthcare stock to hit a $1 trillion market valuation in late 2025, Eli Lilly (LLY 1.29%) hasn't performed well since, with its shares...

Is This Stock a Buy on the Dip?
TipRanks 3d
Eli Lilly & Co Slides as Bold Pipeline Tested

Eli Lilly & Co ( (LLY) ) has fallen by -8.33%. Read on to learn why. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools fo...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.